DGX vs TGTX · P/E 22, rev $5.94B vs P/E 18, rev $240.3M
Quest Diagnostics Incorporated (DGX) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the DGX and TGTX stock pages for the full models.
Not investment advice.